Dura Substitute Market

Dura Substitute Market (Material: Biological Grafts and Synthetic Grafts; Application: Neurosurgery and Spinal Surgery; and End-user: Hospitals, Ambulatory Surgical Center, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Dura Substitute Market Outlook 2031

  • The global dura substitute market was valued at US$ 175.6 Mn in 2020
  • It is estimated to expand at a CAGR of 5.9% from 2021 to 2031
  • The global dura substitute market is expected to reach the value of US$ 328.6 Mn by the end of 2031

Analysts’ Viewpoint on Dura Substitute Market Scenario

Healthcare providers in the dura substitute market are increasing efforts to improve the quality of life for patients with musculoskeletal disorders amid the ongoing coronavirus pandemic. It has been found that xenografts could cause complications such as graft disintegration, encapsulation, and scarring in patients. Hence, healthcare companies should increase R&D in regenerative medicine to overcome complications of xenografts.

Manufacturers are increasing the production of FDA-approved degradable materials such as biomimetic patch made of poly-L-lactic acid, which holds promising potentials to improve patient outcomes. Researchers have attempted to employ various synthetic polymers to make dural substitutes in order to minimize the spread of diseases caused by the use of allogeneic or xenogeneic materials for increasing clinical effectiveness and reduce costs.

Rise in Number of Neurological Treatments Triggering Demand for Dura Substitutes

The high prevalence of CNS (Central Nervous System) tumors caused by neurological disorders is emerging as a driver for companies in the dura substitute market. Chiari malformation and spinal cord related neurosurgery procedures are fuelling the demand for dura substitutes.

The rise in the number of neurological treatments, such as duraplasty, is triggering the demand for dura substitutes. It has been found that in 2018, more than half of all dural substitutes were utilized in cranial and spine tumor surgeries.

dura substitute market infographic

Healthcare Companies Increasing Availability of Grafts During Coronavirus Pandemic

Healthcare services have been affected due to the ongoing coronavirus pandemic. Elective procedures have been postponed indefinitely in the dura substitute market. Neurosurgeons are being redeployed to treat COVID-19 patients. Recent cases of the Omicron variant are creating concerns for healthcare providers. Since coronavirus affects the brain of individuals, participants in the dura substitute market are improving their healthcare services to enable better patient outcomes.

There is a requirement of compulsory training to the neurosurgeon community to understand the symptoms of the novel infection. As such, participants in the market are increasing the availability of biological grafts & synthetic grafts to ensure continuity in healthcare services. They are increasing efforts to revive R&D activities to gain proficiency in neurosurgical and spinal surgeries.

R&D Investment and Regenerative Medicine Hold Potentials to Improve Surgical Outcomes

Complications associated with dura substitute materials are affecting market growth. For instance, autologous tissue is generally preferred for commercialized dura replacements as it reduces the chances of infection and rejection. However, if there is insufficient local replacement tissue of sufficient quality to heal the dural defect, surgeons may avoid autografts. Hence, investments in R&D for materials and government initiatives to promote regenerative medicine hold promising potentials to improve surgical procedures.

Since governments across the world are realizing the importance of regenerative medicine, such trends are translating into revenue opportunities for companies in the dura substitute market.

dura substitute market segmentation

Government Funding in Regenerative Medicine Contributing to Market Growth

Government funding for the treatment of various diseases is increasing globally due to the formulation and adoption of supporting legislation & policies. Such trends are contributing to expansion of the regenerative medicine sector in the dura substitute market.

Healthcare companies are drawing significant expenditure in regenerative medicines such as the establishment of centers of excellence, manufacturing infrastructure, and research networks, among others. The NIH (National Institutes of Health) Common Fund facilitated the establishment of the NIH Center for Regenerative Medicine in 2010 with the purpose of serving as a national resource for stem cell sciences. Such developments are helping to accelerate the development of novel medical applications and cell-based therapeutics.

Transition from Animal Tissue-derived Materials to Synthetic Materials Aiding Market Growth

Dural repair materials are transitioning from animal tissue-derived materials to synthetic materials as well as from inert to absorbable properties. Such findings are bringing a significant change in the global dura substitute market.

Biomimetic patch is a new dural repair product that provides functional properties similar to alternate therapies. This patch has a 3 dimensional (3D) non-woven microfiber structure that is both mechanically strong and biocompatible. The animal investigation revealed that the biomimetic patch and commercially synthesized material groups demonstrated new subdural regeneration after 90 days, with low inflammatory response and minimal to no adhesion development at each stage. It has been found that the biomimetic structure and proper rate of degradation of the new absorbable dura replacement can lead significant regeneration of the dura mater.

Dura Substitute Market: Overview

  • Dural substitute is a type of medical device used in surgeries to repair dura mater, the outermost layer that covers and protects the brain. Animal collagen or nanofibers woven together with an elastic material to form a soft tamponade can also be used to create a dural substitute.
  • Dural substitutes are required to prevent CSF leaks and to allow dural openings to heal after surgery. Dural substitutes can be biological or synthetic, harvested from animals or human cadavers, and used as an onlay or suturable grafts. The key advantage of using a dural substitute is that it is similar to the patient's dura and can absorb and integrate into the host tissue.
  • Rise in the number of road accidents and sports injuries, which increases the need of neurosurgery, is the major factor boosting market growth. However, product recalls is likely to hamper market growth.

Dura Substitute Market: Key Drivers

  • Prevalence of CNS tumors caused by neurological disorders is increasing. Chiari malformation and spinal cord tumor-related neurosurgery procedures that necessitate dural grafts have become more common.
  • Rise in prevalence of neurological diseases requires neurosurgical treatments as well as duraplasty for effective and safe treatment outcomes. In 2018, more than half of all dural substitutes were utilized in cranial and spine tumor surgeries. This is expected to continue in the near future. Therefore, rise in prevalence of neurosurgical diseases leads to an increase in cranial and spinal duraplasty procedures, which in turn is anticipated to boost the demand for dura substitutes.
  • Researchers have attempted to employ various synthetic polymers to make dural substitutes in order to minimize the spread of diseases caused by the use of allogeneic or xenogeneic materials, increase clinical effectiveness, and reduce costs
  • Synthetic macromolecular materials, in comparison to collagen-based dura substitutes, lack the biological functions of stimulating cell migration and boosting the production of related cytokines. Scientists have attempted to create dura substitutes by incorporating gelatin or silk fibroin into the polymer. This approach not only assures the bionic structure of the dural replacement, but also enhances the material's biological function and surface properties, improving its repair effects.
  • Therefore, benefits such as enhanced clinical effectiveness, increased safety, and minimal adverse effects associated with synthetic dura substitutes are anticipated to fuel the growth of the dura substitute market

Market Segmentation: Dura Substitute Market

  • In terms of material, the global dura substitute market has been bifurcated into biological graft and synthetic graft. The biological graft segment has been split into autografts, allografts, and xenografts. The synthetic segment has been segregated into polytetrafluoroethylene and others.
  • Based on application, the global dura substitute market has been classified into neurosurgery and spinal surgery
  • In terms of end-user, the global dura substitute market has been divided into hospitals, ambulatory surgical centers, and others
  • Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The dura substitute market report provides current and expected revenue (US$ Mn) for each of these segments from 2021 to 2031, considering 2020 as the base year. The compound annual growth rate (percentage CAGR) has been provided for each segment and market from 2021 to 2031 along with market size estimations.

Regional Overview: Dura Substitute Market

  • In terms of region, the global dura substitute market has been segmented into North America, Europe, Latin America, Asia Pacific, and Middle East & Africa
  • North America dominated the global dura substitute market in 2020, accounting for 41.8% share. Developed healthcare infrastructure and presence of patient-specific healthcare systems fuel the growth of the dura substitute market in North America.
  • The U.S. dominated the market in North America due to rapid adoption of new technologies for soft tissue repair, presence of key players, and higher penetration of research activities across the country
  • Moreover, growing burden of neurosurgical diseases is leading to increase in cranial and spinal duraplasty, which, in turn, is likely to boost the demand for dura substitute in the region

Major Players

  • The dura substitute market report concludes with the company profiles section, which includes key information about major players in the global dura substitute market
  • Leading players analyzed in the report include
    • Cook Medical LLC
    • B. Braun Melsungen AG
    • Integra LifeSciences
    • Cousin Surgery
    • W. L. Gore & Associates, Inc.
    • Biosynth Lifesciences
    • Acera Surgical, Inc.
    • Medprin
    • Medtronic
    • Stryker
    • DePuy Synthes
    • Gunze Limited
    • Baxter
    • Bennett Health, Inc.
    • RTI Surgical
    • Natus Medical Incorporated
  • Each of these players has been profiled in the dura substitute market report based on parameters such as company overview, financial overview, business strategies, application portfolio, business segments, and recent developments

Dura Substitute Market Snapshot

Attribute

Detail

Market Size Value in 2020

US$ 175.6 Mn

Market Forecast Value in 2031

US$ 328.6 Mn

Growth Rate (CAGR)

5.9%

Forecast Period

2021–2031

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.

Competition Landscape

  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Market Segmentation

  • By Material
    • Biological Grafts
      • Autografts
      • Allografts
      • Xenogrfts
        • Decellularized Pericardium
        • Small Intestine Submucosa
        • Collagen
    • Synthetic Grafts
      • Polytetrafluoroethylene (PTFE)
      • Others
  • By Application
    • Neurosurgery
    • Spinal Surgery
  • By End-user
    • Hospitals
    • Ambulatory Surgical Centers
    • Others

Regions Covered

  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Finland
  • Iceland
  • Norway
  • Rest of Europe
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

Companies Profiled

  • Cook Medical LLC
  • B. Braun Melsungen AG
  • Integra LifeSciences
  • Cousin Surgery
  • W. L. Gore & Associates, Inc.
  • Biosynth Lifesciences 
  • Acera Surgical, Inc.
  • Medprin
  • Medtronic
  • Stryker
  • DePuy Synthes
  • Gunze Limited
  • Baxter
  • Bennett Health, Inc.
  • RTI Surgical
  • Natus Medical Incorporated
  • Other prominent players

Customization Scope

Available upon request

Pricing

Available upon request

Frequently Asked Questions

What is the total market worth of dura substitute market?

Dura substitute market is expected to reach the value of US$ 328.6 Mn by the end of 2031

What is the anticipated CAGR of the dura substitute market in the forecast period?

Dura substitute market is estimated to expand at a CAGR of 5.9% from 2021 to 2031

What are the key driving factors for the growth of the dura substitute market?

Dura substitute market is driven by rise in the number of road accidents and sports injuries

What are the end-use segments in the dura substitute market?

The end-use segments in dura substitute market are hospitals and ambulatory surgical centers

Who are the key players in the global dura substitute market?

Key players operating in the global market include Cook Medical LLC, B. Braun Melsungen AG, Integra LifeSciences, Cousin Surgery, W. L. Gore & Associates, Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Dura Substitute Market

4. Market Overview

    4.1. Introduction

        4.1.1. Material Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Dura Substitute Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Technological Advancements

    5.2. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)

    5.3. Pricing Analysis

    5.4. Product /Brand Analysis, by Application

    5.5. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Dura Substitute Market Analysis and Forecast, by Material

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value Forecast, by Material, 2017–2031

        6.3.1. Biological Grafts

            6.3.1.1. Autografts

            6.3.1.2. Allografts

            6.3.1.3. Xenografts

                6.3.1.3.1. Collagen

                6.3.1.3.2. Decellularized Pericardium

                6.3.1.3.3. Small Intestine Submucosa

        6.3.2. Synthetic

            6.3.2.1. Polytetrafluoroethylene (PTFE)

            6.3.2.2. Others

    6.4. Market Attractiveness Analysis, by Material

7. Global Dura Substitute Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value Forecast, by Application, 2017–2031

        7.3.1. Neurosurgery

        7.3.2. Spinal Surgery

    7.4. Market Attractiveness Analysis, by Application

8. Global Dura Substitute Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value Forecast, by End-user, 2017–2031

        8.3.1. Hospitals

        8.3.2. Ambulatory Surgical Centers

        8.3.3. Others

    8.4. Market Attractiveness Analysis, by End-user

9. Global Dura Substitute Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Market Value Forecast, by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Market Attractiveness Analysis, by Region

10. North America Dura Substitute Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value Forecast, by Material, 2017–2031

        10.2.1. Biological Grafts

            10.2.1.1. Autografts

            10.2.1.2. Allografts

            10.2.1.3. Xenografts

                10.2.1.3.1. Collagen

                10.2.1.3.2. Decellularized Pericardium

                10.2.1.3.3. Small Intestine Submucosa

        10.2.2. Synthetic

            10.2.2.1. Polytetrafluoroethylene (PTFE)

            10.2.2.2. Others

    10.3. Market Value Forecast, by Application, 2017–2031

        10.3.1. Neurosurgery

        10.3.2. Spinal Surgery

    10.4. Market Value Forecast, by End-user, 2017–2031

        10.4.1. Hospitals

        10.4.2. Ambulatory Surgical Centers

        10.4.3. Others

    10.5. Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. Market Attractiveness Analysis

        10.6.1. By Material

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. U.S Dura Substitute Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value Forecast, by Material, 2017–2031

        11.2.1. Biological Grafts

        11.2.2. Synthetic

    11.3. Market Value Forecast, by Application, 2017–2031

        11.3.1. Neurosurgery

        11.3.2. Spinal Surgery

    11.4. Market Attractiveness Analysis

        11.4.1. By Material

        11.4.2. By Application

12. Canada Dura Substitute Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value Forecast, by Material, 2017–2031

        12.2.1. Biological Grafts

        12.2.2. Synthetic

    12.3. Market Value Forecast, by Application, 2017–2031

        12.3.1. Neurosurgery

        12.3.2. Spinal Surgery

    12.4. Market Attractiveness Analysis

        12.4.1. By Material

        12.4.2. By Application

13. Europe Dura Substitute Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value Forecast, by Material, 2017–2031

        13.2.1. Biological Grafts

            13.2.1.1. Autografts

            13.2.1.2. Allografts

            13.2.1.3. Xenografts

                13.2.1.3.1. Collagen

                13.2.1.3.2. Decellularized Pericardium

                13.2.1.3.3. Small Intestine Submucosa

        13.2.2. Synthetic

            13.2.2.1. Polytetrafluoroethylene (PTFE)

            13.2.2.2. Others

    13.3. Market Value Forecast, by Application, 2017–2031

        13.3.1. Neurosurgery

        13.3.2. Spinal Surgery

    13.4. Market Value Forecast, by End-user, 2017–2031

        13.4.1. Hospitals

        13.4.2. Ambulatory Surgical Centers

        13.4.3. Others

    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Germany

        13.5.2. U.K

        13.5.3. France

        13.5.4. Italy

        13.5.5. Spain

        13.5.6. Denmark

        13.5.7. Sweden

        13.5.8. Finland

        13.5.9. Iceland

        13.5.10. Norway

        13.5.11. Rest of Europe

    13.6. Market Attractiveness Analysis

        13.6.1. By Material

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Germany Dura Substitute Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value Forecast, by Material, 2017–2031

        14.2.1. Biological Grafts

        14.2.2. Synthetic

    14.3. Market Value Forecast, by Application, 2017–2031

        14.3.1. Neurosurgery

        14.3.2. Spinal Surgery

    14.4. Market Attractiveness Analysis

        14.4.1. By Material

        14.4.2. By Application

15. U.K Dura Substitute Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value Forecast, by Material, 2017–2031

        15.2.1. Biological Grafts

        15.2.2. Synthetic

    15.3. Market Value Forecast, by Application, 2017–2031

        15.3.1. Neurosurgery

        15.3.2. Spinal Surgery

    15.4. Market Attractiveness Analysis

        15.4.1. By Material

        15.4.2. By Application

16. France Dura Substitute Market Analysis and Forecast

    16.1. Introduction

        16.1.1. Key Findings

    16.2. Market Value Forecast, by Material, 2017–2031

        16.2.1. Biological Grafts

        16.2.2. Synthetic

    16.3. Market Value Forecast, by Application, 2017–2031

        16.3.1. Neurosurgery

        16.3.2. Spinal Surgery

    16.4. Market Attractiveness Analysis

        16.4.1. By Material

        16.4.2. By Application

17. Italy Dura Substitute Market Analysis and Forecast

    17.1. Introduction

        17.1.1. Key Findings

    17.2. Market Value Forecast, by Material, 2017–2031

        17.2.1. Biological Grafts

        17.2.2. Synthetic

    17.3. Market Value Forecast, by Application, 2017–2031

        17.3.1. Neurosurgery

        17.3.2. Spinal Surgery

    17.4. Market Attractiveness Analysis

        17.4.1. By Material

18. Competition Landscape

    18.1. Market Player - Competition Matrix (by tier and size of companies)

    18.2. Market Share Analysis, by Company, 2020

    18.3. Company Profiles

        18.3.1. Cook Medical LLC

            18.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.1.2. Product Portfolio

            18.3.1.3. SWOT Analysis

            18.3.1.4. Strategic Overview

        18.3.2. B. Braun Melsungen AG

            18.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.2.2. Product Portfolio

            18.3.2.3. SWOT Analysis

            18.3.2.4. Strategic Overview

        18.3.3. Integra LifeSciences

            18.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.3.2. Product Portfolio

            18.3.3.3. SWOT Analysis

            18.3.3.4. Strategic Overview

        18.3.4. Cousin Surgery

            18.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.4.2. Product Portfolio

            18.3.4.3. SWOT Analysis

            18.3.4.4. Strategic Overview

        18.3.5. W. L. Gore & Associates, Inc.

            18.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.5.2. Product Portfolio

            18.3.5.3. SWOT Analysis

            18.3.5.4. Strategic Overview

        18.3.6. Biosynth Lifesciences

            18.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.6.2. Product Portfolio

            18.3.6.3. SWOT Analysis

            18.3.6.4. Strategic Overview

        18.3.7. Acera Surgical, Inc.

            18.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.7.2. Product Portfolio

            18.3.7.3. SWOT Analysis

            18.3.7.4. Strategic Overview

        18.3.8. Medprin

            18.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.8.2. Product Portfolio

            18.3.8.3. SWOT Analysis

            18.3.8.4. Strategic Overview

        18.3.9. Medtronic

            18.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.9.2. Product Portfolio

            18.3.9.3. SWOT Analysis

            18.3.9.4. Strategic Overview

        18.3.10. Stryker

            18.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.10.2. Product Portfolio

            18.3.10.3. SWOT Analysis

            18.3.10.4. Strategic Overview

        18.3.11. DePuy Synthes

            18.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.11.2. Product Portfolio

            18.3.11.3. SWOT Analysis

            18.3.11.4. Strategic Overview

        18.3.12. Gunze Limited

            18.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.12.2. Product Portfolio

            18.3.12.3. SWOT Analysis

            18.3.12.4. Strategic Overview

        18.3.13. Baxter

            18.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.13.2. Product Portfolio

            18.3.13.3. SWOT Analysis

            18.3.13.4. Strategic Overview

        18.3.14. Bennett Health, Inc.

            18.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.14.2. Product Portfolio

            18.3.14.3. SWOT Analysis

            18.3.14.4. Strategic Overview

        18.3.15. RTI Surgical

            18.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.15.2. Product Portfolio

            18.3.15.3. SWOT Analysis

            18.3.15.4. Strategic Overview

        18.3.16. Natus Medical Incorporated

            18.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            18.3.16.2. Product Portfolio

            18.3.16.3. SWOT Analysis

            18.3.16.4. Strategic Overview

List of Tables

Table 01: Global Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 02: Global Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 03: Global Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 04: Global Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 05: Global Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 06: Global Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 07: Global Dura Substitute Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 08: North America Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 09: North America Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 10: North America Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 11: North America Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 12: North America Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 13: North America Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 14: North America Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 15: U.S Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 16: U.S Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Canada Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 18: Canada Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 19: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 21: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 22: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 23: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 24: Europe Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 25: Europe Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 26: Germany Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 27: Germany Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 28: U.K. Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 29: U.K Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 30: France Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 31: France Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 32: Spain Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 33: Spain Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 34: Italy Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 35: Italy Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 36: Denmark Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 37: Denmark Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 38: Sweden Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 39: Sweden Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 40: Finland Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 41: Finland Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 42: Iceland Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 43: Iceland Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 44: Norway Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 45: Norway Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 46: Rest of Europe Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 47: Rest of Europe Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 48: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 49: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 50: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 51: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 52: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 53: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 54: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 55: China Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 56: China Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 57: Japan Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 58: Japan Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 59: India Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 60: India Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 61: South Korea Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 62: South Korea Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 63: Australia Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 64: Australia Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 65: Rest of Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 66: Rest of Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 67: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 68: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 69: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 70: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 71: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 72: Latin America Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 73: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Material, 2017–2031

Table 74: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Biological Grafts, 2017–2031

Table 75: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Xenografts, 2017–2031

Table 76: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Synthetic, 2017–2031

Table 77: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 78: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Dura Substitute Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Dura Substitute Market Value Share, by Material, 2020

Figure 03: Global Dura Substitute Market Value Share, by Application, 2020

Figure 04: Global Dura Substitute Market Value Share, by End-user, 2020

Figure 05: Global Dura Substitute Market Value Share, by Region, 2020

Figure 06: Global Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 07: Global Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 08: Global Dura Substitute Market Value (US$ Mn), by Biological Grafts, 2017–2031

Figure 09: Global Dura Substitute Market Value (US$ Mn), by Synthetic, 2017–2031

Figure 10: Global Dura Substitute Market Value (US$ Mn), by Xenografts, 2017–2031

Figure 11: Global Dura Substitute Market Value (US$ Mn), by Autografts, 2017–2031

Figure 12: Global Dura Substitute Market Value (US$ Mn), by Allografts, 2017–2031

Figure 13: Global Dura Substitute Market Value (US$ Mn), by Trichomoniasis, 2017–2031

Figure 14: Global Dura Substitute Market Value (US$ Mn), by Others, 2017–2031

Figure 15: Global Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 16: Global Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 17: Global Dura Substitute Market Value (US$ Mn), by Neurosurgery, 2017–2031

Figure 18: Global Dura Substitute Market Value (US$ Mn), by Spinal Surgery, 2017–2031

Figure 19: Global Dura Substitute Market Value (US$ Mn), by Others, 2017–2031

Figure 20: Global Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 21: Global Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 22: Global Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Figure 23: Global Dura Substitute Market Value (US$ Mn), by Hospitals, 2017–2031

Figure 24: Global Dura Substitute Market Value (US$ Mn), by Ambulatory Surgical Centers, 2017–2031

Figure 25: Global Dura Substitute Market Value (US$ Mn), by Others, 2017–2031

Figure 26: Global Dura Substitute Market Analysis, 2020 and 2031

Figure 27: Global Dura Substitute Market Attractiveness Analysis, by Region, 2021–2031

Figure 28: North America Dura Substitute Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: North America Dura Substitute Market Value Share, by Country/Sub-region, 2020–2031

Figure 30: North America Dura Substitute Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 31: North America Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 32: North America Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 33: North America Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 34: North America Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 35: North America Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 36: North America Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Figure 37: U.S Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 38: U.S Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 39: U.S Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 40: U.S Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 41: Canada Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 42: Canada Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 43: Canada Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 44: Canada Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 45: Europe Dura Substitute Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 46: Europe Dura Substitute Market Value Share, by Country/Sub-region, 2020–2031

Figure 47: Europe Dura Substitute Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 48: Europe Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 49: Europe Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 50: Europe Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 51: Europe Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Figure 52: Germany Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 53: Germany Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 54: Germany Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 55: Germany Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 56: U.K. Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 57: U.K. Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 58: U.K. Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 59: U.K. Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 60: France Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 61: France Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 62: France Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 63: France Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 64: Spain Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 65: Spain Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 66: Spain Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 67: Spain Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 68: Italy Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 69: Italy Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 70: Italy Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 71: Italy Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 72: Denmark Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 73: Denmark Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 74: Denmark Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 75: Denmark Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 76: Sweden Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 77: Sweden Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 78: Sweden Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 79: Sweden Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 80: Finland Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 81: Finland Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 82: Finland Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 83: Finland Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 84: Iceland Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 85: Iceland Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 86: Iceland Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 87: Iceland Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 88: Norway Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 89: Norway Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 90: Norway Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 91: Norway Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 92: Rest of Europe Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 93: Rest of Europe Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 94: Rest of Europe Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 95: Rest of Europe Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 96: Asia Pacific Dura Substitute Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 97: Asia Pacific Dura Substitute Market Value Share, by Country/Sub-region, 2020–2031

Figure 98: Asia Pacific Dura Substitute Market Attractiveness, by Country/Sub-region, 2021–2031

Figure 99: Asia Pacific Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 100: Asia Pacific Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 101: Asia Pacific Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 102: Asia Pacific Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 103: Asia Pacific Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 104: Asia Pacific Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Figure 105: China Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 106: China Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 107: China Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 108: China Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 109: Japan Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 110: Japan Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 111: Japan Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 112: Japan Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 113: India Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 114: India Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 115: India Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 116: India Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 117: South Korea Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 118: South Korea Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 119: South Korea Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 120: South Korea Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 121: Australia Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 122 Australia Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 123: Australia Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 124: Australia Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 125: Rest of Asia Pacific Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 126: Rest of Asia Pacific Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 127: Rest of Asia Pacific Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 128: Rest of Asia Pacific Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 129: Latin America Dura Substitute Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 130: Latin America Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 131: Latin America Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 132: Latin America Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 133: Latin America Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 134: Latin America Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 135: Latin America Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Figure 136: Middle East & Africa Dura Substitute Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 137: Middle East & Africa Dura Substitute Market Value Share Analysis, by Material, 2020 and 2031

Figure 138: Middle East & Africa Dura Substitute Market Attractiveness Analysis, by Material, 2021–2031

Figure 139: Middle East & Africa Dura Substitute Market Value Share Analysis, by Application, 2020 and 2031

Figure 140: Middle East & Africa Dura Substitute Market Attractiveness Analysis, by Application, 2021–2031

Figure 141: Middle East & Africa Dura Substitute Market Value Share Analysis, by End-user, 2020 and 2031

Figure 142: Middle East & Africa Dura Substitute Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved